Skip to content
Recovery & autonomic healthEvidence review3 min read

Women with PCOS have lower heart rate variability than women without it, in 17 studies

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis. · Systematic reviews · 2024 · Original paper ↗

Key takeaway

Pooling 17 studies, women with polycystic ovary syndrome (PCOS) had lower heart rate variability (HRV) than controls, for example SDNN with an SMD of -0.763 (95% CI -1.289 to -0.237). The studies varied in quality from low to high risk of bias, and HRV was not reduced in women with obesity.

Study design

Evidence review

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

PCOS is a common hormonal condition in women of reproductive age with metabolic problems, and low HRV, a marker of autonomic nervous system dysfunction, is linked to adverse cardiovascular events. The authors asked whether women with PCOS show altered cardiac autonomic function, as measured by HRV.

Who and how

Systematic review and meta-analysis reported following PRISMA, searching PubMed, Scopus, Web of Science and Cochrane. Risk of bias was assessed with ROBINS-I for non-randomized studies and the certainty of evidence with GRADE. A random-effects model pooled standardized mean differences (SMD) with 95% CIs, and subgroup and sensitivity analyses explored the high heterogeneity.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    17 articles were included, ranging from low to high risk of bias. Overall, HRV was notably lower in women with PCOS than in controls.
  2. 2
    Time-domain measures were lower: SDNN (SMD -0.763, 95% CI -1.289 to -0.237, p = 0.004) and PNN50 (SMD -1.245, 95% CI -2.07 to -0.419, p = 0.003).
  3. 3
    Frequency-domain results pointed the same way: higher LF/HF ratio (SMD 0.670, 95% CI 0.248 to 1.091, p = 0.002) and LFnu (SMD 0.840, 95% CI 0.428 to 1.251), and lower HFnu (SMD -0.873, 95% CI -1.257 to -0.489) and total power (TP; SMD -1.997, 95% CI -3.306 to -0.687, p = 0.003).
  4. 4
    Study design explained part of the heterogeneity. HRV was significantly altered in normal-weight and overweight women with PCOS, but not significantly changed in those with obesity.

Limits & uncertainty

  1. 1
    Heterogeneity was high, only partly explained by study design, so the pooled differences hide variation between studies.
  2. 2
    The included studies were mostly non-randomized and ranged from low to high risk of bias, which weakens confidence in the pooled estimates.
  3. 3
    The abstract does not give the number of participants, the GRADE ratings or the HRV recording conditions, which differ between studies.
  4. 4
    Lower HRV in PCOS is an association with unclear causes, and this reading is based on the abstract only.

What to take from it

The finding adds to evidence that PCOS may involve autonomic nervous system changes, which is a reason clinicians pay attention to cardiovascular health in PCOS. A lower HRV reading is not a diagnosis, and women with PCOS should discuss heart health and any concerns with their clinician.

Reading your own data

Wearables estimate HRV overnight or at rest, and your own trend matters more than any average. Measure at the same time and under the same conditions with the same device, because HRV values differ between devices and measurement methods, and do not compare yours with the study's group differences.

How to read this evidence

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Objectives

Polycystic ovary syndrome (PCOS) is a prevalent and complex endocrine disorder that affects women of reproductive age. It has significant implications for female endocrine function, reproductive health, and metabolic disturbances, including insulin resistance, impaired glucose tolerance, and dyslipidemia. Studies have shown that decreased heart rate variability (HRV), a marker of autonomic dysfunction, is associated with adverse cardiovascular events. Recent research has focused on investigating autonomic function in PCOS, and some studies have suggested altered autonomic drive in these patients. The aim of this systematic review and meta-analysis was to evaluate cardiac autonomic function by analyzing HRV in women with PCOS.

Methods

This systematic review was prepared using PRISMA reporting guidelines. The databases searched were PubMed, Scopus, Web of Science, and Cochrane. Risk of Bias was assessed using ROBINS-I for non-RCTs. The GRADE approach was employed to evaluate the level of certainty in the evidence for each outcome. In order to identify the underlying cause of high heterogeneity, a subgroup analysis was conducted. Sensitivity analysis was checked. A random effect model was used and calculated a pooled standardized mean difference (SMD) with a 95% confidence interval (CI).

Results

Seventeen articles were included in the final analysis, varied in quality, ranging from a "low" to a "high risk of bias". Combined analyses indicated a notable decrease in HRV among individuals with PCOS compared to the control group. Significant changes were observed in SDNN (SMD: -0.763, 95%CI [-1.289 to -0.237], p=0.004), PNN50 (SMD: -1.245, 95%CI [-2.07, -0.419], p=0.003), LF/HF ratio (SMD: 0.670, 95%CI [0.248, 1.091], p=0.002), HFnu (SMD: -0.873, 95%CI [-1.257, -0.489], p=0.000), LFnu (SMD: 0.840, 95%CI [0.428, 1.251], p=0.000) and TP (SMD: -1.997, 95%CI [-3.306, -0.687], p=0.003). The heterogeneity was partially explained by types of study design. Subgroup analysis revealed significant alterations of HRV in normal-weighted and overweight PCOS cases. Conversely, no significant changes in HRV were observed in obese PCOS cases.

Conclusion

The findings of this meta-analysis provide evidence suggesting diminished HRV in individuals with PCOS compared to non-PCOS control group.

Sources & attribution

Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis.

Mirzohreh ST, Panahi P, Heidari F.

Systematic reviews · 2024-07-24

DOI: 10.1186/s13643-024-02617-x ↗PubMed · 39049099 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Research article

Short-term HRV was higher during slow breathing in 962 military men, injured or not

In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.

European Journal of Applied Physiology

In-depth explainersRead study →
·Trial meta-analysis

Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain

Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.

PeerJ

In-depth explainersRead study →
·Evidence review

Cold-water immersion after hard exercise: less soreness, better power, no strength gain

In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.

Sports Medicine

In-depth explainersRead study →
·Methods & interpretation

Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue

The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.

International Journal of Sports Physiology and Performance

In-depth explainersRead study →
Recovery & autonomic health →